Emmaus Life Sciences Announces SFDA (Saudi Food & Drug Authority) Accepts Endari® Priority Review Request Apr 16, 2020 8:00am EDT
Emmaus Life Sciences Provides Update in Response to the Coronavirus (COVID-19) Pandemic Mar 24, 2020 8:00am EDT
Emmaus Life Sciences Announces Equity Purchase Agreement for up to $25 Million with Lincoln Park Capital Mar 03, 2020 8:00am EST
Emmaus Life Sciences Reports Preliminary Gross Sales for the Three Months Ended December 31, 2019 Feb 05, 2020 8:00am EST
Emmaus Life Sciences Reports Positive Top-Line Preliminary Results in First Patient in Diverticulosis Pilot Trial Jan 29, 2020 8:00am EST
Emmaus Life Sciences Expresses Concerns Over Inaccuracies in Draft Report Issued by ICER (Institute for Clinical and Economic Review) Jan 27, 2020 8:00am EST
Emmaus Life Sciences Announces a New Adherence Program for Its Sickle Cell Disease Patients Jan 06, 2020 8:00am EST
Emmaus Life Sciences Announces First Purchase Order from its Partnership with taiba Healthcare Dec 31, 2019 4:01pm EST
Emmaus Life Sciences Announces Update of its Partnership with taiba Healthcare to Expand Patient Access for Sickle Cell Disease Treatment in the Middle East and North Africa (MENA) Region Dec 23, 2019 4:01pm EST
